Barbara Dietrich

769 total citations
24 papers, 572 citations indexed

About

Barbara Dietrich is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Barbara Dietrich has authored 24 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 8 papers in Immunology and 5 papers in Genetics. Recurrent topics in Barbara Dietrich's work include Complement system in diseases (7 papers), Platelet Disorders and Treatments (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Barbara Dietrich is often cited by papers focused on Complement system in diseases (7 papers), Platelet Disorders and Treatments (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Barbara Dietrich collaborates with scholars based in Austria, United States and Germany. Barbara Dietrich's co-authors include Andrey V. Kozlov, Hans Nohl, Hanspeter Rottensteiner, Alexandra Schiviz, Friedrich Scheiflinger, Apostolos Chatzitomaris, Hans Peter Schwarz, Rudolf Hoermann, Steffen Hering and J.E.M. Midgley and has published in prestigious journals such as Blood, Journal of Virology and British Journal of Pharmacology.

In The Last Decade

Barbara Dietrich

21 papers receiving 553 citations

Peers

Countries citing papers authored by Barbara Dietrich

Since Specialization

Citations

This map shows the geographic impact of Barbara Dietrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Dietrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Dietrich more than expected).

Fields of papers citing papers by Barbara Dietrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Dietrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Dietrich. The network helps show where Barbara Dietrich may publish in the future.

Co-authorship network of co-authors of Barbara Dietrich

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Dietrich. A scholar is included among the top collaborators of Barbara Dietrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Dietrich. Barbara Dietrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pre-clinical characterization of CSL040, a soluble complement receptor 1 (CR1) fragment 2025 ·Immunobiology ·Sandra Wymann, Tanja Ruthsatz, Anjan K. Bongoni, (unknown), (unknown), (unknown), (unknown), (unknown), David Tai Leong, Elena Velkoska, (unknown), Kirstee L. Martin, Barbara Dietrich, Peter J. Cowan, Tony Rowe, Adriana Baz Morelli, Matthew P. Hardy	0
2	Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeys 2024 ·Toxicology and Applied Pharmacology ·Tanja Ruthsatz, Sandra Wymann, Elena Velkoska, Mariam Mansour, (unknown), (unknown), Paolo Rossato, Michael Fitzpatrick, (unknown), (unknown), Eva Herzog, Kirstee L. Martin, Barbara Dietrich, (unknown)	1
3	Co-administration of CSL112 (apolipoprotein A-I [human]) with atorvastatin and alirocumab is not associated with increased hepatotoxic or toxicokinetic effects in rats 2021 ·Toxicology and Applied Pharmacology ·Andrea Beyerle, Brandon Greene, Barbara Dietrich, Bronwyn A. Kingwell, (unknown), Samuel D. Wright, Eva Herzog	2
4	Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis 2017 ·European Journal of Pharmacology ·(unknown), (unknown), Bernhard Baumgartner, Barbara Dietrich, Patrice Douillard, Randolf J. Kerschbaumer, (unknown), (unknown), (unknown), Frederick W.K. Tam, Michael Thiele, (unknown), Martin J. Wolfsegger, (unknown), (unknown), Friedrich Scheiflinger, Helmut Glantschnig	5
5	Thyroid Allostasis–Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming 2017 ·Frontiers in Endocrinology ·Apostolos Chatzitomaris, Rudolf Hoermann, J.E.M. Midgley, Steffen Hering, (unknown), Barbara Dietrich, (unknown), Harald Klein, Johannes W. Dietrich	111
6	Preclinical assessment of a new recombinant ADAMTS‐13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura 2016 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), Christina Piskernik, Barbara Plaimauer, Frank Horling, (unknown), Tanja Ruthsatz, Barbara Dietrich, Eva M. Muchitsch, F. Scheiflinger, (unknown), (unknown)	21
7	Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes 2015 ·Expert Review of Clinical Pharmacology ·Peter L. Turecek, (unknown), Srilatha Tangada, (unknown), Herbert Gritsch, Hanspeter Rottensteiner, Gerald Schrenk, Artur Mitterer, Barbara Dietrich, (unknown), Alexandra Schiviz, Frank Horling, Birgit M. Reipert, (unknown), Borislava G. Pavlova, Friedrich Scheiflinger	6
8	Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B 2013 ·International Journal of Hematology ·Barbara Dietrich, Alexandra Schiviz, (unknown), Frank Horling, (unknown), Hanspeter Rottensteiner, Peter L. Turecek, Hans Peter Schwarz, Friedrich Scheiflinger, (unknown)	14
9	Physiologie seelischer Traumata und posttraumatischer Belastungsstörungen (PTBS) 2013 ·Barbara Dietrich	0
10	Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study 2012 ·Journal of Crohn s and Colitis ·Klaus Herrlinger, Mircea Diculescu, Klaus Fellermann, H Hartmann, Stefanie Howaldt, (unknown), Andrej Petrov, Wolfgang Reindl, J.‐M. Otte, (unknown), Ulrike Strauch, Andreas Sturm, (unknown), Aldo Ammendola, Barbara Dietrich, (unknown), Eduard F. Stange	58
11	Preclinical Safety of Baxter's Recombinant ADAMTS13 2012 ·Blood ·Christina Piskernik, Barbara Dietrich, (unknown), Tanja Ruthsatz, Friedrich Scheiflinger, Hans Peter Schwarz, (unknown)	1
12	Preclinical Safety Pharmacology of Baxter’s Longer Acting rFVIII (BAX 855) 2011 ·Blood ·Barbara Dietrich, (unknown), Hartmut J. Ehrlich, Friedrich Scheiflinger, Hans Peter Schwarz, (unknown)	2
13	Safety of Baxter’s Longer Acting rFVIII (BAX 855) After Repeated Application in Rats and Cynomolgus Monkeys 2011 ·Blood ·Barbara Dietrich, Margit Spatzenegger, Reinhard Stidl, Martin J. Wolfsegger, Hartmut J. Ehrlich, Friedrich Scheiflinger, Hans Peter Schwarz, (unknown)	4
14	Preclinical Testing of Human Recombinant von Willebrand Factor: ADAMTS13 Cleavage Capacity in Animals as Criterion for Species Suitability 2010 ·Seminars in Thrombosis and Hemostasis ·(unknown), Barbara Dietrich, Hanspeter Rottensteiner, Wilfried Auer, Dirk Nehrbass, Herbert Gritsch, Hartmut J. Ehrlich, Peter L. Turecek, Hans Peter Schwarz	11
15	A note on statistical analysis of organ weights in non-clinical toxicological studies 2009 ·Toxicology and Applied Pharmacology ·Martin J. Wolfsegger, Thomas Jaki, Barbara Dietrich, (unknown), Kerry Barker	26
16	Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection 2009 ·Journal of Virology ·(unknown), (unknown), (unknown), Georg W. Holzer, Michael G. Schwendinger, P Brühl, Marijan Gerenčer, Brian A. Crowe, Shuo Shen, (unknown), Yee‐Joo Tan, Barbara Dietrich, Nicolas Sabarth, Helga Savidis-Dacho, Otfried Kistner, Perry Barrett, Falko G. Falkner	25
17	Caroverine, a multifunctional drug with antioxidant functions 2003 ·BioFactors ·Hans Nohl, (unknown), Barbara Dietrich, (unknown), Andrey V. Kozlov	22
18	Various intracellular compartments cooperate in the release of nitric oxide from glycerol trinitrate in liver 2003 ·British Journal of Pharmacology ·Andrey V. Kozlov, Barbara Dietrich, Hans Nohl	56
19	Single dose human pharmacology of umespirone 1994 ·European Journal of Clinical Pharmacology ·(unknown), Keith Wesnes, Barbara Dietrich	20
20	Grundrente und Wohnungsfrage 1974 ·KJ / Kritische Justiz ·Barbara Dietrich	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact